Eduardo Gonzalez Pons, MD
Vascular & Interventional Radiology · Manati, PRNPI 1316133978
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Angiodynamics, Inc. at 40.9% of the total. Reporting peaked in 2019 at $3,237 and has fallen 82.7% since, to $560 in 2025. Among vascular & interventional radiology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $93.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$3K
- Boston Scientific$1K
- Medtronic$1K
- BD$793
- Bard Peripheral Vascular, Inc.$465
- Penumbra, Inc.$164
- plus $608 from 10 others
What the payments were for
- Travel & lodging$1,93925%
- Food & beverage$2,67934%
- Education$3,20041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $3,200 |
| Boston Scientific | 11 | $1,351 |
| Medtronic(2 entities) | 12 | $1,237 |
| BD | 27 | $793 |
| Bard Peripheral Vascular, Inc. | 21 | $465 |
| Penumbra, Inc. | 1 | $164 |
| Davol Inc. | 1 | $134 |
| Bard Access Systems, Inc. | 1 | $129 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Terumo Medical Corporation | 1 | $79 |
| AstraZeneca | 1 | $38 |
| AbbVie | 1 | $26 |
| Clovis Oncology, Inc. | 1 | $25 |
| Covidien LP | 1 | $24 |
| Eisai Inc. | 1 | $17 |
| Cordis US CORP. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVLT$3,200
- ELLIPSYS VASCULAR ACCESS SYSTEM$1,010
- DIREXION$1,003
- LIFESTREAM$263
- Indigo System$164
- GENERAL EMBOLICS$135
- TARPEYO$125
How this compares
$7,817 in reported general payments places this provider in the 95th percentile of 27 vascular & interventional radiology providers in Puerto Rico.
See all vascular & interventional radiology providers in Puerto Rico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 96 | $842 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Manati
- Carlos AnayaManati$18K
- Stephanie Torres-AyalaMayaguez$7K
- Roberto Kutcher-DiazSan Juan$6K
- Angel Torres RiveraMayaguez$4K
- Manuel Betancourt TorresLuquillo$3K
- Jesus BuonomoPonce$2K
- Alejandro Hidalgo RiosSan Juan$2K
- Brandon PaganDorado$2K
- Javier Nazario LarrieuBayamon$2K
- Jorge Arzola ColonHato Rey$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.